Nuo Therapeutics, Inc. 8-K

What Happened
Nuo Therapeutics, Inc. (ticker: AURX) filed a Form 8‑K on May 14, 2026 (Item 2.02) to announce its first-quarter 2026 financial results. The company furnished a press release reporting its quarterly results as Exhibit 99 to the filing; that press release is incorporated by reference into the 8‑K.

Key Details

• Filing date: May 14, 2026 (Form 8‑K).
• Item reported: 2.02 — Results of Operations and Financial Condition (press release announcing Q1 2026 results).
• Exhibit included: Exhibit 99 — press release dated May 14, 2026.
• Technical exhibit: 104 — Inline XBRL cover page data embedded in the filing.

Why It Matters
This 8‑K notifies investors that Nuo has published its Q1 2026 quarterly results (earnings, revenue and related financial condition) via a press release. Investors should read Exhibit 99 to see the specific revenue, net income (or loss), cash position and any commentary on operations or outlook, since those details drive reactions in the share price and help evaluate near‑term financing and operational prospects. The 8‑K itself simply furnishes the release; any material metrics or guidance will be found in the press release.